An Open Protocol for the Compassionate Use of Thalidomide
NCT00081757
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
250
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Thalidomide
Sponsor
University of Arkansas